Showing 1 - 4 results of 4 for search 'Gerd R Burmester', query time: 0.02s Refine Results
  1. 1
    Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study

    Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study by Daniel E Furst, Paul Emery, Gerd R Burmester, Vivian P Bykerk, Bernard G Combe, Michael A Maldonado, Tom WJ Huizinga

    Published 2019-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Benefit–risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease

    Benefit–risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease by Roy Fleischmann, Stephen Hall, Gerd R Burmester, Eduardo Mysler, Peter Taylor, Tianming Gao, Sander Strengholt, Bettina Wick-Urban, Andrew Garrison, Irina Fish

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study

    Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study by Sandra Hermann, Gerd R Burmester, Sarah Ohrndorf, Marina Backhaus, Paula Hoff, Jens Klotsche, Anne-Marie Glimm, Schahrasad Lisa Ridha Ali, Gabriela Schmittat

    Published 2021-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension

    Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension by Gerd R Burmester, Mark C Genovese, Vibeke Strand, Gregory St John, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Susan Boklage

    Published 2019-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: